Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Return on Assets (2023 - 2025)

Historic Return on Assets for Indivior Pharmaceuticals (INDV) over the last 3 years, with Q3 2025 value amounting to 0.09%.

  • Indivior Pharmaceuticals' Return on Assets rose 500.0% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.0% for FY2024, which is 800.0% up from last year.
  • Latest data reveals that Indivior Pharmaceuticals reported Return on Assets of 0.09% as of Q3 2025, which was up 500.0% from 0.08% recorded in Q2 2025.
  • In the past 5 years, Indivior Pharmaceuticals' Return on Assets registered a high of 0.09% during Q3 2025, and its lowest value of 0.22% during Q3 2023.
  • In the last 3 years, Indivior Pharmaceuticals' Return on Assets had a median value of 0.01% in 2025 and averaged 0.03%.
  • Within the past 5 years, the most significant YoY rise in Indivior Pharmaceuticals' Return on Assets was 2600bps (2024), while the steepest drop was -700bps (2024).
  • Over the past 3 years, Indivior Pharmaceuticals' Return on Assets (Quarter) stood at 0.0% in 2023, then skyrocketed by 554bps to 0.01% in 2024, then soared by 1686bps to 0.09% in 2025.
  • Its Return on Assets was 0.09% in Q3 2025, compared to 0.08% in Q2 2025 and 0.01% in Q1 2025.